Xcout IntelAlamar Biosciences, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Alamar Biosciences, Inc. among biotech companies — ranked by similarity to what Alamar Biosciences, Inc. actually does, not by market-cap band.
Subscribe to see Alamar Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Alamar Biosciences, Inc.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Alamar Biosciences, Inc. at a glance
Alamar Biosciences, Inc. is a biotech company headquartered in Fremont, United States. It is publicly listed (ALMR) with a market capitalisation of $1.8B. Xcout tracks 17 named people at Alamar Biosciences, Inc., including Timothy O. White (President). Xcout recorded 47 job postings from Alamar Biosciences, Inc. in the last 90 days.
Alamar Biosciences, Inc. leadership
- Timothy O. WhitePresident
- Justin J. McAnearChief Financial Officer
- Xiao-Jun MaChief Technology Officer
- Stephen A. WilliamsChief Scientific Officer
- Yuling LuoCo-Founder, Chairman & CEO
- Shiping ChenCo-Founder, COO & Director
11 more named people on record for Alamar Biosciences, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Alamar Biosciences, Inc.
Xcout recorded 47 job postings from Alamar Biosciences, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Alamar Biosciences, Inc.'s hiring signals →
Recent Alamar Biosciences, Inc. news
- PartnershipAlamar Biosciences Partners with Leading Research ...
- IPOIPO registration (S-1)
- IPOAlamar Biosciences files for IPO amid opening life sciences ...
- IPOIPO registration (S-1)
7 corporate events on record, with sources — see the full timeline →
Top 12 Alamar Biosciences, Inc. competitors
Ranked by semantic similarity — how close each company is to Alamar Biosciences, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Olink Proteomics provides high-throughput protein biomarker analysis products, instruments, software, and analysis services for life science research and drug development. Utilizing its proprietary Proximity Extension Assay (PEA) technology and next-generation sequencing, the company serves researchers and pharmaceutical organizations focused on biomarker discovery and precision medicine.
Biotechnology
Intus Biosciences develops proprietary microbiome analysis technology that combines patented science, long-read sequencing, and AI to deliver strain-level resolution of microbial data. The company serves healthcare providers, researchers, and consumers through clinical-grade profiling products like GutID and research partnerships aimed at drug development and biomarker discovery.
Life Sciences
Biotrove, Inc., founded in 1997, is a developer and manufacturer of genomic analysis instruments, consumables, and technology platforms such as OpenArray. The company provides systems and services for molecular diagnostics, high-throughput screening, drug discovery, and life sciences research.
Biotechnology
Esya Labs is a biotechnology and life sciences company with a corporate office located in Frisco, Texas. The company partners with entities like Alamar Biosciences to advance scientific research and diagnostics.
Biotechnology
SomaLogic, Inc. is an active biotechnology company headquartered in Boulder, Colorado, specializing in proteomics technology and biomarker discovery.
Biotechnology
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Similar biotech company
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.
Similar biotech company
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, as well as to academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Biotechnology
Novilytic develops bioanalytical products and kits, notably the Proteometer platform, which streamlines protein-quality analysis for pharmaceutical laboratories. The company's technology enables rapid assessment of titer, aggregates, and charge variants for monoclonal antibodies, multispecifics, and fusion proteins while eliminating traditional sample preparation and purification steps.
Similar biotech company
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Biotechnology
Glyphic Biotechnologies is a biotechnology research company headquartered in Berkeley, California, dedicated to next-generation proteome sequencing and rewriting the rules of proteomics.
Biotechnology
Adarza BioSystems, Inc. is a biotechnology company headquartered in St. Louis, Missouri, focused on label-free detection biosystems and life sciences solutions.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Alamar Biosciences, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Alamar Biosciences, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →